Marc Ringelhan

4.9k total citations · 1 hit paper
25 papers, 1.7k citations indexed

About

Marc Ringelhan is a scholar working on Epidemiology, Hepatology and Immunology. According to data from OpenAlex, Marc Ringelhan has authored 25 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Epidemiology, 15 papers in Hepatology and 6 papers in Immunology. Recurrent topics in Marc Ringelhan's work include Liver Disease Diagnosis and Treatment (10 papers), Hepatitis B Virus Studies (9 papers) and Hepatitis C virus research (7 papers). Marc Ringelhan is often cited by papers focused on Liver Disease Diagnosis and Treatment (10 papers), Hepatitis B Virus Studies (9 papers) and Hepatitis C virus research (7 papers). Marc Ringelhan collaborates with scholars based in Germany, United States and France. Marc Ringelhan's co-authors include Mathias Heikenwälder, Tracy O’Connor, Dominik Pfister, Eli Pikarsky, Ulrike Protzer, Roland M. Schmid, Fabian Geisler, Percy A. Knolle, Philipp J. Jost and Martin F. Sprinzl and has published in prestigious journals such as Journal of Clinical Investigation, The EMBO Journal and Nature Immunology.

In The Last Decade

Marc Ringelhan

24 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The immunology of hepatocellular carcinoma

2018 755 citations Marc Ringelhan, Dominik Pfister et al. Nature Immunology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marc Ringelhan Germany	14	629	588	536	500	452	25	1.7k
Guo‐Huan Yang China	17	334 0.5×	952 1.6×	504 0.9×	292 0.6×	732 1.6×	38	2.1k
Atsushi Takai Japan	22	193 0.3×	560 1.0×	395 0.7×	296 0.6×	435 1.0×	69	1.5k
Toshihiko Ohtomo Japan	18	419 0.7×	721 1.2×	234 0.4×	150 0.3×	319 0.7×	31	1.5k
Constantinos P. Zambirinis United States	16	720 1.1×	466 0.8×	123 0.2×	260 0.5×	685 1.5×	26	1.6k
Orlando Musso France	23	138 0.2×	812 1.4×	403 0.8×	286 0.6×	427 0.9×	40	1.6k
Makiko Kawaguchi Japan	22	318 0.5×	559 1.0×	234 0.4×	122 0.2×	312 0.7×	72	1.3k
F. Facchetti Italy	23	274 0.4×	479 0.8×	1.2k 2.2×	1.3k 2.7×	454 1.0×	89	2.2k
Amarsanaa Jazag Japan	20	185 0.3×	885 1.5×	174 0.3×	215 0.4×	443 1.0×	29	1.4k
Laurent Mailly France	16	346 0.6×	732 1.2×	401 0.7×	434 0.9×	171 0.4×	25	1.4k
Kenta Yoshiura Japan	14	128 0.2×	863 1.5×	524 1.0×	310 0.6×	298 0.7×	34	1.8k

Countries citing papers authored by Marc Ringelhan

Since Specialization

Citations

This map shows the geographic impact of Marc Ringelhan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc Ringelhan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc Ringelhan more than expected).

Fields of papers citing papers by Marc Ringelhan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marc Ringelhan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc Ringelhan. The network helps show where Marc Ringelhan may publish in the future.

Co-authorship network of co-authors of Marc Ringelhan

This figure shows the co-authorship network connecting the top 25 collaborators of Marc Ringelhan. A scholar is included among the top collaborators of Marc Ringelhan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marc Ringelhan. Marc Ringelhan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Würstle, Silvia, Alexander Hapfelmeier, Roland M. Schmid, et al.. (2023). Differentiation of Spontaneous Bacterial Peritonitis from Secondary Peritonitis in Patients with Liver Cirrhosis: Retrospective Multicentre Study. Diagnostics. 13(5). 994–994. 2 indexed citations

Fasoula, Nikolina‐Alexia, Angelos Karlas, Olga Prokopchuk, et al.. (2023). Non-invasive multispectral optoacoustic tomography resolves intrahepatic lipids in patients with hepatic steatosis. Photoacoustics. 29. 100454–100454. 12 indexed citations

Mogler, Carolin, Silke Wunderlich, Maximilian Reichert, et al.. (2023). Fulminant Liver Failure after Treatment with a Checkpoint Inhibitor for Gastric Cancer: A Case Report and Review of the Literature. Journal of Clinical Medicine. 12(14). 4641–4641. 3 indexed citations

Ringelhan, Marc, Ursula Ehmer, Jochen Schneider, et al.. (2022). (Seltene) infektiöse Hepatitiden als wichtige Differenzialdiagnose der unklaren Hepatopathie. PubMed. 44(1). 53–62.

Knolle, Percy A., Katrin Böttcher, Ulrike Bauer, et al.. (2022). Fatty acids directly limit mucosal-associated invariant T cell effector function in non-alcoholic fatty liver disease. Journal of Hepatology. 77. S189–S189. 1 indexed citations

Zhao, Lili, Marc Ringelhan, Karin Wisskirchen, et al.. (2021). Hepatitis B virus envelope proteins can serve as therapeutic targets embedded in the host cell plasma membrane. Cellular Microbiology. 23(12). e13399–e13399. 6 indexed citations

Michler, Thomas, Anna D. Kosinska, Julia Festag, et al.. (2020). Knockdown of Virus Antigen Expression Increases Therapeutic Vaccine Efficacy in High-Titer Hepatitis B Virus Carrier Mice. Gastroenterology. 158(6). 1762–1775.e9. 92 indexed citations

Ringelhan, Marc, Dominik Pfister, Tracy O’Connor, Eli Pikarsky, & Mathias Heikenwälder. (2018). The immunology of hepatocellular carcinoma. Nature Immunology. 19(3). 222–232. 755 indexed citations breakdown →

Quasdorff, Maria, Romina Bester, Silke Arzberger, et al.. (2018). Hepatitis B virus promotes β-catenin-signalling and disassembly of adherens junctions in a Src kinase dependent fashion. Oncotarget. 9(74). 33947–33960. 13 indexed citations

10.

Hösel, Marianna, Maria Quasdorff, Marc Ringelhan, et al.. (2017). Hepatitis B Virus Activates Signal Transducer and Activator of Transcription 3 Supporting Hepatocyte Survival and Virus Replication. Cellular and Molecular Gastroenterology and Hepatology. 4(3). 339–363. 28 indexed citations

11.

Wolf, Benita, Christine S. Falk, Kai Breuhahn, et al.. (2016). Inducing Differentiation of Premalignant Hepatic Cells as a Novel Therapeutic Strategy in Hepatocarcinoma. Cancer Research. 76(18). 5550–5561. 13 indexed citations

12.

Ringelhan, Marc & Ulrike Protzer. (2015). Oncogenic potential of hepatitis B virus encoded proteins. Current Opinion in Virology. 14. 109–115. 20 indexed citations

13.

Jörs, Simone, Petia Jeliazkova, Marc Ringelhan, et al.. (2015). Lineage fate of ductular reactions in liver injury and carcinogenesis. Journal of Clinical Investigation. 125(6). 2445–2457. 125 indexed citations

14.

Yabal, Monica, Nicole Müller, Heiko Adler, et al.. (2014). XIAP Restricts TNF- and RIP3-Dependent Cell Death and Inflammasome Activation. Cell Reports. 7(6). 1796–1808. 191 indexed citations

15.

Ringelhan, Marc, Tracy O’Connor, Ulrike Protzer, & Mathias Heikenwälder. (2014). The direct and indirect roles of HBV in liver cancer: prospective markers for HCC screening and potential therapeutic targets. The Journal of Pathology. 235(2). 355–367. 103 indexed citations

16.

Ringelhan, Marc, Florian Reisinger, Detian Yuan, Achim Weber, & Mathias Heikenwälder. (2014). Modeling Human Liver Cancer Heterogeneity: Virally Induced Transgenic Models and Mouse Genetic Models of Chronic Liver Inflammation. Current Protocols in Pharmacology. 67(1). 14.31.1–14.31.17. 3 indexed citations

17.

Sprinzl, Martin F., Florian Reisinger, Andreas S. Puschnik, et al.. (2013). Sorafenib perpetuates cellular anticancer effector functions by modulating the crosstalk between macrophages and natural killer cells. Hepatology. 57(6). 2358–2368. 135 indexed citations

18.

Ringelhan, Marc, Mathias Heikenwälder, & Ulrike Protzer. (2013). Direct Effects of Hepatitis B Virus-Encoded Proteins and Chronic Infection in Liver Cancer Development. Digestive Diseases. 31(1). 138–151. 45 indexed citations

19.

Ringelhan, Marc, Roland M. Schmid, & Fabian Geisler. (2012). The NF-κB Subunit RelA/p65 Is Dispensable for Successful Liver Regeneration after Partial Hepatectomy in Mice. PLoS ONE. 7(10). e46469–e46469. 17 indexed citations

20.

Sarbia, Mario, et al.. (2012). Acanthosis nigricans als paraneoplastische Erkrankung des Ösophagus: ein Fallbericht. Zeitschrift für Gastroenterologie. 50(7). 680–683. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact